The overdiagnosis nightmare: A time for caution

BMC Women's Health

Volumn 9, Issue , 2009, Pages

  Ciatto, Stefano ^a  

^a Marzana Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; HUMAN; INTERMETHOD COMPARISON; MAMMOGRAPHY; NIGHTMARE; NOTE; RELIABILITY; WOMEN'S HEALTH; BREAST TUMOR; CANCER INVASION; DENMARK; DIAGNOSTIC ERROR; FEMALE; INCIDENCE; LABORATORY DIAGNOSIS; MASS SCREENING; PATHOLOGY; RISK FACTOR; STATISTICS;

BREAST NEOPLASMS; DENMARK; DIAGNOSTIC ERRORS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; NEOPLASM INVASIVENESS; RISK FACTORS; WOMEN'S HEALTH;

EID: 74049130326     PISSN: None     EISSN: 14726874     Source Type: Journal    
DOI: 10.1186/1472-6874-9-34     Document Type: Note

References (15)

1. Jørgensen KJ, Gøtzsche PC. Overdiagnosis in publicly organized mammography screening programmes: Systematic review of incidence trends. Br Med J 2009, 339:b2587.
2. Perry NM, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L. European guidelines for quality assurance in breast cancer screening and diagnosis. 2006, Luxembourg: European Commission, Fourth.
3. Holund B. Latent prostatic cancer in a consecutive autopsy series. Scand J Urol Nephrol 1980, 14:29-43.
4. Draisma G, Boer R, Otto SJ, Cruijsen IW, Damhuis RA, Schröder FH. Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst 2003, 95:868-78.
5. Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009, 360:1320-8. 10.1056/NEJMoa0810084, 19297566.
6. Zappa M, Ciatto S, Bonardi R, Mazzotta A. Overdiagnosis of prostate carcinoma by screening: an estimate based on the results of the Florence Screening Pilot Study. Ann Oncol 1998, 9:1297-300. 10.1023/A:1008492013196, 9932159.
7. Ciatto S, Houssami N, Martinelli F, Giusti F, Zappa M. PSA use and incidence of prostate biopsy in the Tuscany Region: is opportunistic screening discounting biopsy in subjects with PSA elevation?. Tumori 2008, 94:518-22.
8. Welch HG, Black WC. Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast: how much more breast cancer can we find?. Ann Intern Med 1997, 127:1023-8.
9. Jonsson H, Johansson R, Lenner P. Increased incidence of invasive breast cancer after the introduction of service screening with mammography in Sweden. nt J Cancer 2005, 117:I842-7.
10. Duffy SW, Lynge E, Jonsson H, Ayyaz S, Olsen AH. Complexities in estimation of overdiagnosis in breast cancer screening. Br J Cancer 2008, 99:1176-8. 10.1038/sj.bjc.6604638, 2567065, 18766185.
11. Zappa M, Spagnolo G, Ciatto S, Giorgi D, Paci E, Rosselli Del Turco M. Measurement of the costs in two mammographic screening programmes in the province of Florence, Italy. J Med Screen 1995, 2:191-4.
12. Duffy SW, Agbaje O, Tabar L, Vitak B, Bjurstam N, Björneld L. Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer. Breast Cancer Res 2005, 7:258-65. 1-5 gotehnburg two county, 10.1186/bcr1354, 1410738, 16457701.
13. Moss S. Overdiagnosis and overtreatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening. Breast Cancer Res 2005, 7:230-4. 10.1186/bcr1314, 1242166, 16168145.
14. Puliti D, Zappa M, Miccinesi G, Falini P, Crocetti E, Paci E. An estimate of overdiagnosis 15 years after the start of mammographic screening in Florence. Eur J Cancer 2009,
15. Paci E, Warwick J, Falini P, Duffy SW. Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern?. J Med Scree 2004, 11:23-7. 5.